IL43431A - N-(5-alkyl-2-amidophenyl)-n',n"-bis-(alkoxycarbonyl)-guanidines,their production and pharmaceutical compositions containing them - Google Patents

N-(5-alkyl-2-amidophenyl)-n',n"-bis-(alkoxycarbonyl)-guanidines,their production and pharmaceutical compositions containing them

Info

Publication number
IL43431A
IL43431A IL43431A IL4343173A IL43431A IL 43431 A IL43431 A IL 43431A IL 43431 A IL43431 A IL 43431A IL 4343173 A IL4343173 A IL 4343173A IL 43431 A IL43431 A IL 43431A
Authority
IL
Israel
Prior art keywords
compound according
hereinbefore described
diluent
radical
admixture
Prior art date
Application number
IL43431A
Other versions
IL43431A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL43431A0 publication Critical patent/IL43431A0/en
Publication of IL43431A publication Critical patent/IL43431A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Furan Compounds (AREA)

Claims (27)

WHAT WE CLAIM IS:
1. Compounds which are phenylguanidine derivatives following general formula in which X is an n-butyl radical; R^" is an alkyl radical with 1 to 4 carbon atoms; 2 R is an alkyl radical with 1 to 4 carbon atoms, a cyclohexyl radical, a phenyl radical or a (C-^-C^) alkylamino or a (C^-C^) alkoxy- (C^-C^) alkylamino. radical.
2. Compounds according to Claim 1 in which R1 is a methyl, ethyl, isopropyl or sec-butyl radical.
3. The compound according to Claim 1 that is hereinbefore described in Example 1.
4. The compound according to Claim 1 that is hereinbefore described in Example 2.
5. The compound according to Claim 1 that is hereinbefore described in Example 4.
6. The compound according to Claim 1 that is hereinbefore described in Example 5.
7. The compound according to Claim 1 that is hereinbefore described in Example 7.
8. The compound according to Claim 1 that is hereinbefore described in Example 8.
9. Compounds according to Claim 1 that are hereinbefore specifically mentioned other than those according to Claims
10. A process for the production of a compound according any of claims 1 to 9-·, in which a 2-a.minoaniline derivative of the general formula: - is reacted with an isothiourea of the general formula :- [in which general formulae X, R and R are as defined in any of Claims 1 to 4 and R is an alkyl radical with 1 to 4 carbon atoms] .
11. A process according to Claim 10 in which the reaction is carried out in a polar organic solvent as diluent.
12. A process according to Claim 10 or 11 in which the reaction is carried out in the presence of hydrochloric acid, sulphuric acid, nitric acid, formic acid, acetic acid, or p_-toluenesulphonic acid:
13. A process according to Claim 10, H or 12 in which the reaction is carried out at 60 to 100°C.
14. A process for the production of a compound according to any of Claims 1 to 9 substantially as hereinbefore described in Example 1.
15. Compounds according to Claim 1 whenever produced by a process according to any of Claims 10 to 14.
16. A pharmaceutical composition containing as an active ingredient a compound according to any of Claims 1 to 9 and 15 in admixture with a solid or liquified gaseous diluent or in admixture ..with a liquid diluent other than a solvent of 43431/2 i
17. A pharmaceutical composition containing as an active ingredient a compound according to any of Claims 1 to 9 and 15 in the form of a sterile or isotonic aqueous solution.
18. A composition according to Claim 16 or 17 containing from 0.5 to 90 weight percent of active ingredient.
19. A pharmaceutical composition according to Claim 16, 17 or 18 substantially as hereinbefore described.
20. A medicament in dosage unit form comprising a compound according to any of Claims 1 to 9 and 15 either alone or in admixture with> a diluent.
21. A medicament in the form of tablets, pills, dragees, capsules, ampoules or suppositories comprising a compound according to any of Claims 1 to 9 and 15, either alone or in admixture with a diluent.
22. A medicament according to Claim .20 or 21 substantially as hereinbefore described.
23. A method of combatting helmintic infestation in non-human animals comprising administering to the animals an active compound according to any of Claims 1 to 9 and 15, either alone or in admixture with a diluent or in the form of a medicament according to Claim 20, 21 or 22.
24. A method according to Claim 23 in which the active compound is administered in an amount of 1 to 100 mg/kg body weight per day.
25. A method according to Claim 23 or 24 in which the active compound is administered perorally.
26. A method according to Claim 23, 24 or 25 in which the helmintic infestation is of hookworms, Tri~c hostrongylides , Strongylides , Rhabditides , eelworms or whipworms. i
27. A method according to any of Claims 23 to 26 substantially as hereinbefore described or as illustrated
IL43431A 1972-10-18 1973-10-16 N-(5-alkyl-2-amidophenyl)-n',n"-bis-(alkoxycarbonyl)-guanidines,their production and pharmaceutical compositions containing them IL43431A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2250911A DE2250911A1 (en) 1972-10-18 1972-10-18 PHENYLGUANIDINE DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT

Publications (2)

Publication Number Publication Date
IL43431A0 IL43431A0 (en) 1974-01-14
IL43431A true IL43431A (en) 1976-04-30

Family

ID=5859304

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43431A IL43431A (en) 1972-10-18 1973-10-16 N-(5-alkyl-2-amidophenyl)-n',n"-bis-(alkoxycarbonyl)-guanidines,their production and pharmaceutical compositions containing them

Country Status (23)

Country Link
JP (2) JPS4971123A (en)
AR (1) AR199121A1 (en)
AT (1) AT338818B (en)
AU (1) AU475701B2 (en)
BE (1) BE806201A (en)
CA (1) CA992554A (en)
CH (1) CH586195A5 (en)
CS (1) CS168049B2 (en)
DE (1) DE2250911A1 (en)
EG (1) EG11195A (en)
ES (1) ES419721A1 (en)
FR (1) FR2203631B1 (en)
GB (1) GB1414244A (en)
HU (1) HU166358B (en)
IE (1) IE38387B1 (en)
IL (1) IL43431A (en)
KE (1) KE2628A (en)
LU (1) LU68627A1 (en)
NL (1) NL7314183A (en)
PH (1) PH10760A (en)
SE (1) SE386436B (en)
SU (1) SU489315A3 (en)
ZA (1) ZA738075B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2651467A1 (en) * 1976-11-11 1978-05-18 Bayer Ag SUBSTITUTED O-PHENYLENE DIAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICINAL PRODUCTS
US6593466B1 (en) 1999-07-07 2003-07-15 Isis Pharmaceuticals, Inc. Guanidinium functionalized nucleotides and precursors thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108835A1 (en) * 1970-10-09 1972-05-26 Rhone Poulenc Sa Fungicidal guanidines from o phenylenediamine
DE2109454A1 (en) * 1971-02-27 1972-09-14 Farbenfabriken Bayer Ag, 5090 Leverkusen Fungicidal n-(2-acylaminophenyl)-n,n-bis(alkoxycarbonyl)-guanidines - from 2-acrylaminoanilines and s-alkyl n,n-bis(alkoxycarbonyl) isothiazole

Also Published As

Publication number Publication date
AR199121A1 (en) 1974-08-08
AU475701B2 (en) 1976-09-02
FR2203631B1 (en) 1977-09-09
CA992554A (en) 1976-07-06
IE38387L (en) 1974-04-18
PH10760A (en) 1977-09-02
AT338818B (en) 1977-09-12
SU489315A3 (en) 1975-10-25
CS168049B2 (en) 1976-05-28
HU166358B (en) 1975-03-28
IE38387B1 (en) 1978-03-01
JPS4971123A (en) 1974-07-10
KE2628A (en) 1976-05-28
AU6150573A (en) 1975-04-17
LU68627A1 (en) 1973-12-27
GB1414244A (en) 1975-11-19
ES419721A1 (en) 1976-03-01
EG11195A (en) 1977-11-30
JPS4986341A (en) 1974-08-19
NL7314183A (en) 1974-04-22
ZA738075B (en) 1974-08-28
CH586195A5 (en) 1977-03-31
SE386436B (en) 1976-08-09
DE2250911A1 (en) 1974-04-25
ATA878973A (en) 1977-01-15
FR2203631A1 (en) 1974-05-17
IL43431A0 (en) 1974-01-14
BE806201A (en) 1974-04-17

Similar Documents

Publication Publication Date Title
JPH07502512A (en) Amidino derivatives and their use as nitric oxide synthase inhibitors
KR970061865A (en) Newly substituted guanidine derivatives, methods for their preparation, and pharmaceutical uses thereof
US3666856A (en) Treating immune response with amino purine derivatives
ES2096840T3 (en) SUBSTITUTED BENZOILGUANIDINES, PROCEDURE FOR THEIR PREPARATION, USE AS A MEDICATION OR AGENT FOR DIAGNOSIS, AS WELL AS A MEDICINAL PRODUCT CONTAINING THEM.
GB2063252A (en) Lincomycin and clindamycin derivatives
US2951843A (en) Tetrahydrosoquinoline biguanides
GB1429144A (en) Pharmaceutical compositions
IL43079A (en) 2-amino-1,4-dihydropyridines,their production and pharmaceutical compositions containing them
IL43431A (en) N-(5-alkyl-2-amidophenyl)-n',n"-bis-(alkoxycarbonyl)-guanidines,their production and pharmaceutical compositions containing them
US4086235A (en) 5 (6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
IL43063A (en) 2-phenoxy-1-imidazolyl-alkan-3-ones their production and pharmaceutical compositions containing them
US4038479A (en) Amino purine derivatives
Cope et al. Benzoates, p-aminobenzoates and phenylurethans of 2-alkylaminoethanols
US3375165A (en) Fusidic acid salts of tetracycline bases and therapy
IL43757A (en) Penicillins,their production and pharmaceutical compositions containing them
US3637826A (en) Tetracycline derivative
EP0560136B1 (en) Neuroprotective drug
IL41664A (en) 2,6-diamino-dihydropyridines,their production and pharmaceutical compositions containing them
US2905590A (en) Thioxanthene derivative
US3116327A (en) Upsilon-dimethylaminopropyl isothiourea and acid addition salts thereof
IL33364A (en) 2-hydroxymethyl-3-carbamoyl-quinoxaline 1,4-dioxides,their production,and pharmaceutical and feed compositions containing them
US3461161A (en) Water-soluble tetracycline derivatives
US3766168A (en) N6-(chlorobuten - 2 - yl)-adenosines and processes for the preparation thereof
US2921091A (en) N1-carbamidomethyl-n2-(beta-hydroxyethyl) urea
IL42745A (en) 2-amino-4-h-pyrane derivatives,their production and pharmaceutical compositions containing them